Literature DB >> 12496922

Day to day changes in free and total PSA: significance of biological variation.

R G Nixon1, M H Wener, K M Smith, R E Parson, A B Blase, M K Brawer.   

Abstract

In this study we evaluated the physiological variation of free and total prostate-specific antigen (PSA) levels to determine how the percent free/total PSA was affected. Twenty four patients had blood drawn for ten consecutive weekdays. The percent coefficient of variation (%CV) of biological variation was calculated. The results were log-normally distributed with geometric means of 12.0% CV, 7.3% CV, and 8.8% CV for free, total, and percent free/total PSA, respectively. When applied, the percent free/total, PSA would need to fluctuate by 31% to indicate that a significant change (critical difference, P<0.05) between two measurements had occurred. Biological variation of PSA measurements is substantial.

Entities:  

Year:  1997        PMID: 12496922     DOI: 10.1038/sj.pcan.4500212

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  4 in total

Review 1.  Tumor markers in prostate cancer I: blood-based markers.

Authors:  Shahrokh F Shariat; Axel Semjonow; Hans Lilja; Caroline Savage; Andrew J Vickers; Anders Bjartell
Journal:  Acta Oncol       Date:  2011-06       Impact factor: 4.089

2.  Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden.

Authors:  Laila Bruun; Charlotte Becker; Jonas Hugosson; Hans Lilja; Anders Christensson
Journal:  Prostate       Date:  2005-11-01       Impact factor: 4.104

3.  Advancing Traditional Prostate-specific Antigen Kinetics in the Detection of Prostate Cancer: A Machine Learning Model.

Authors:  Marlon Perera; Lewis Smith; Ian Thompson; Geoff Breemer; Nathan Papa; Manish I Patel; Peter Swindle; Elliot Smith
Journal:  Eur Urol Focus       Date:  2021-12-14

Review 4.  Screening for prostate cancer: an update.

Authors:  Shahrokh F Shariat; Peter T Scardino; Hans Lilja
Journal:  Can J Urol       Date:  2008-12       Impact factor: 1.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.